PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALT vs. METCB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALT and METCB is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ALT vs. METCB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
28.70%
-7.57%
ALT
METCB

Key characteristics

Sharpe Ratio

ALT:

0.03

METCB:

-0.52

Sortino Ratio

ALT:

0.84

METCB:

-0.52

Omega Ratio

ALT:

1.10

METCB:

0.94

Calmar Ratio

ALT:

0.03

METCB:

-0.58

Martin Ratio

ALT:

0.08

METCB:

-1.31

Ulcer Index

ALT:

42.49%

METCB:

16.65%

Daily Std Dev

ALT:

99.52%

METCB:

42.03%

Max Drawdown

ALT:

-99.94%

METCB:

-37.59%

Current Drawdown

ALT:

-99.70%

METCB:

-37.16%

Fundamentals

Market Cap

ALT:

$640.12M

METCB:

$595.54M

EPS

ALT:

-$1.57

METCB:

$0.67

Total Revenue (TTM)

ALT:

$52.00K

METCB:

$698.13M

Gross Profit (TTM)

ALT:

-$2.01M

METCB:

$127.11M

EBITDA (TTM)

ALT:

-$101.42M

METCB:

$118.58M

Returns By Period

In the year-to-date period, ALT achieves a -26.67% return, which is significantly lower than METCB's -23.14% return.


ALT

YTD

-26.67%

1M

2.48%

6M

28.71%

1Y

4.56%

5Y*

36.27%

10Y*

-34.02%

METCB

YTD

-23.14%

1M

-6.47%

6M

-7.57%

1Y

-22.85%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALT vs. METCB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALT, currently valued at 0.03, compared to the broader market-4.00-2.000.002.000.03-0.52
The chart of Sortino ratio for ALT, currently valued at 0.84, compared to the broader market-4.00-2.000.002.004.000.84-0.52
The chart of Omega ratio for ALT, currently valued at 1.10, compared to the broader market0.501.001.502.001.100.94
The chart of Calmar ratio for ALT, currently valued at 0.06, compared to the broader market0.002.004.006.000.06-0.58
The chart of Martin ratio for ALT, currently valued at 0.08, compared to the broader market-5.000.005.0010.0015.0020.0025.000.08-1.31
ALT
METCB

The current ALT Sharpe Ratio is 0.03, which is higher than the METCB Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of ALT and METCB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.03
-0.52
ALT
METCB

Dividends

ALT vs. METCB - Dividend Comparison

ALT has not paid dividends to shareholders, while METCB's dividend yield for the trailing twelve months is around 7.45%.


TTM2023202220212020201920182017
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.87%
METCB
Ramaco Resources Inc.
7.45%3.14%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

ALT vs. METCB - Drawdown Comparison

The maximum ALT drawdown since its inception was -99.94%, which is greater than METCB's maximum drawdown of -37.59%. Use the drawdown chart below to compare losses from any high point for ALT and METCB. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%JulyAugustSeptemberOctoberNovemberDecember
-40.26%
-37.16%
ALT
METCB

Volatility

ALT vs. METCB - Volatility Comparison

Altimmune, Inc. (ALT) has a higher volatility of 21.94% compared to Ramaco Resources Inc. (METCB) at 17.80%. This indicates that ALT's price experiences larger fluctuations and is considered to be riskier than METCB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
21.94%
17.80%
ALT
METCB

Financials

ALT vs. METCB - Financials Comparison

This section allows you to compare key financial metrics between Altimmune, Inc. and Ramaco Resources Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab